NCT00314860

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 568 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 18 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

Restless Legs Syndrome (RLS) study in adults comparing immediate release ropinirole with extended release ropinirole over 12 weeks

Conditions

• Restless Legs Syndrome
• Restless Legs Syndrome (RLS)

Interventions

Type	Name	Description
DRUG	ropinirole Extended Release (XR)

Timeline

• Start date: 2006-02-01
• Primary completion: 2006-12-01
• Completion: 2006-12-01
• First posted: 2006-04-17
• Last updated: 2016-10-18

Locations

91 sites across 13 countries: United States, Australia, Austria, Belgium, Denmark, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom